Citation: Am. King et al., A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers, SWISS MED W, 131(1-2), 2001, pp. 10-13
Citation: Pl. Vernazza et al., Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health, REV MED MIC, 12(3), 2001, pp. 131-142
Authors:
Chakraborty, H
Sen, PK
Helms, RW
Vernazza, PL
Fiscus, SA
Eron, JJ
Patterson, BK
Coombs, RW
Krieger, JN
Cohen, MS
Citation: H. Chakraborty et al., Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model, AIDS, 15(5), 2001, pp. 621-627
Authors:
Miserez, AR
Muller, PY
Barella, L
Schwietert, M
Erb, P
Vernazza, PL
Battegay, M
Citation: Ar. Miserez et al., A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia, AIDS, 15(15), 2001, pp. 2045-2049
Authors:
Quinlivan, EB
Wang, RX
Stewart, PW
Kolmoltri, C
Regamey, N
Erb, P
Vernazza, PL
Citation: Eb. Quinlivan et al., Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS, J MED VIROL, 64(2), 2001, pp. 157-166
Authors:
Opravil, M
Cone, RW
Fischer, M
Vernazza, PL
Bassetti, S
Lorenzi, P
Bisset, LR
Ott, P
Huber, W
Knuchel, MC
Roos, M
Luthy, R
Weber, R
Citation: M. Opravil et al., Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: A randomized trial of double versus triple therapy, J ACQ IMM D, 23(1), 2000, pp. 17-25
Authors:
Maida, MJ
Daly, CC
Hoffman, I
Cohen, MS
Kumwenda, M
Vernazza, PL
Citation: Mj. Maida et al., Prevalence of Hepatitis C infection in Malawi and lack of association withsexually transmitted diseases, EUR J EPID, 16(12), 2000, pp. 1183-1184
Authors:
Vernazza, PL
Troiani, L
Flepp, MJ
Cone, RW
Schock, J
Roth, F
Boggian, K
Cohen, MS
Fiscus, SA
Eron, JJ
Citation: Pl. Vernazza et al., Potent antiretroviral treatment of HIV-infection results in suppression ofthe seminal shedding of HIV, AIDS, 14(2), 2000, pp. 117-121
Authors:
Rutschmann, OT
Vernazza, PL
Bucher, HC
Opravil, M
Ledergerber, B
Telenti, A
Malinverni, R
Bernasconi, E
Fagard, C
Leduc, D
Perrin, L
Hirschel, B
Citation: Ot. Rutschmann et al., Long-term hydroxyurea in combination with didanosine and stavudine for thetreatment of HIV-1 infection, AIDS, 14(14), 2000, pp. 2145-2151
Citation: Pl. Vernazza et al., Sensitization to human immunodeficiency virus in seronegative exposed partners, J INFEC DIS, 182(6), 2000, pp. 1810-1811
Authors:
Bassetti, S
Battegay, M
Furrer, H
Rickenbach, M
Flepp, M
Kaiser, L
Telenti, A
Vernazza, PL
Bernasconi, E
Sudre, P
Citation: S. Bassetti et al., Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?, J ACQ IMM D, 21(2), 1999, pp. 114-119
Authors:
Schlegel, M
Osterwalder, JJ
Galeazzi, RL
Vernazza, PL
Citation: M. Schlegel et al., Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland: cohort study, BR MED J, 319(7206), 1999, pp. 352-353
Authors:
Wendland, T
Furrer, H
Vernazza, PL
Frutig, K
Christen, A
Matter, L
Malinverni, R
Pichler, WJ
Citation: T. Wendland et al., HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cellresponses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decreasein viraemia, AIDS, 13(14), 1999, pp. 1857-1862
Authors:
Furrer, H
Egger, M
Opravil, M
Bernasconi, E
Hirschel, B
Battegay, M
Telenti, A
Vernazza, PL
Rickenbach, M
Flepp, M
Malinverni, R
Citation: H. Furrer et al., Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy, N ENG J MED, 340(17), 1999, pp. 1301-1306
Authors:
Rutschmann, OT
Opravil, M
Iten, M
Malinverni, R
Vernazza, PL
Bucher, H
Bernasconi, E
Perrin, LH
Yerly, S
Hirschel, B
Citation: Ot. Rutschmann et al., Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up, ANTIVIR TH, 3, 1998, pp. 65-67